AveXis Inc (AVXS): Of Course The FDA Didn’t Ask For Placebo Data

AveXis Inc (NASDAQ:AVXS) just announced that it has secured a favorable trial design for its ongoing investigation of its lead asset, AVXS-101, in its investigation into spinal...

Keep Reading →